loadpatents
name:-0.082870006561279
name:-0.031818151473999
name:-0.029278993606567
YAN; Shunqi Patent Filings

YAN; Shunqi

Patent Applications and Registrations

Patent applications and USPTO patent grants for YAN; Shunqi.The latest application filed is for "compound for treating gout or hyperuricemia".

Company Profile
11.34.50
  • YAN; Shunqi - San Diego CA
  • YAN; Shunqi - Laguna Hills CA
  • Yan; Shunqi - Irvine CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compound For Treating Gout Or Hyperuricemia
App 20220242841 - YAN; Shunqi ;   et al.
2022-08-04
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia
App 20220112171 - YAN; Shunqi ;   et al.
2022-04-14
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
Grant 11,236,058 - Yan , et al. February 1, 2
2022-02-01
Methods For Treating Or Preventing Gout Or Hyperuricemia
App 20220023251 - YAN; Shunqi ;   et al.
2022-01-27
Crystalline Forms Of A Compound For Treating Or Preventing Gout Or Hyperuricemia
App 20220024889 - YAN; Shunqi ;   et al.
2022-01-27
Therapeutic Compounds And Compositions
App 20210198206 - Salituro; Francesco G. ;   et al.
2021-07-01
Therapeutic compounds and compositions
Grant 10,988,448 - Salituro , et al. April 27, 2
2021-04-27
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia
App 20200148659 - YAN; Shunqi ;   et al.
2020-05-14
Therapeutically Active Compounds And Their Methods Of Use
App 20200079755 - Cianchetta; Giovanni ;   et al.
2020-03-12
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
Grant 10,508,093 - Yan , et al. Dec
2019-12-17
Therapeutic Compounds And Compositions
App 20190345109 - Salituro; Francesco G. ;   et al.
2019-11-14
Glutaminase inhibitors and method of use
Grant 10,414,740 - Lemieux , et al. Sept
2019-09-17
Therapeutic Compounds And Compositions
App 20190241523 - Salituro; Francesco G. ;   et al.
2019-08-08
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia
App 20190169150 - YAN; Shunqi ;   et al.
2019-06-06
Therapeutically active compounds and their methods of use
Grant 10,294,215 - Cianchetta , et al.
2019-05-21
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
Grant 10,239,854 - Yan , et al.
2019-03-26
Therapeutic compounds and compositions
Grant 10,202,339 - Popovici-Muller , et al. Feb
2019-02-12
Compounds, Compositions And Methods For Treating Or Preventing A Symptom Associated With Gout Or Hyperuricemia
App 20190040030 - YAN; Shunqi ;   et al.
2019-02-07
Glutaminase Inhibitors And Method Of Use
App 20180370930 - Lemieux; Rene M. ;   et al.
2018-12-27
Therapeutic compounds and compositions
Grant 10,029,987 - Salituro , et al. July 24, 2
2018-07-24
Glutaminase inhibitors and method of use
Grant 10,011,574 - Lemieux , et al. July 3, 2
2018-07-03
Therapeutically active compositions and their methods of use
Grant 9,856,279 - Cao , et al. January 2, 2
2018-01-02
Therapeutically Active Compounds And Their Methods Of Use
App 20170298045 - Cianchetta; Giovanni ;   et al.
2017-10-19
Therapeutically active compounds and their methods of use
Grant 9,732,062 - Cianchetta , et al. August 15, 2
2017-08-15
Therapeutically Active Compositions And Their Methods Of Use
App 20170210749 - Cao; Sheldon ;   et al.
2017-07-27
Inhibitors of bruton's tyrosine kinase
Grant 9,708,326 - Chen , et al. July 18, 2
2017-07-18
Therapeutic Compounds And Compositions
App 20170183311 - Salituro; Francesco G. ;   et al.
2017-06-29
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer
Grant 9,662,327 - Cao , et al. May 30, 2
2017-05-30
Therapeutically active compounds and their methods of use
Grant 9,656,999 - Cianchetta , et al. May 23, 2
2017-05-23
Inhibitors of Bruton's tyrosine kinase
Grant 9,580,416 - Chen , et al. February 28, 2
2017-02-28
Therapeutically Active Compounds And Their Methods Of Use
App 20170044139 - Cianchetta; Giovanni ;   et al.
2017-02-16
Purinone Compounds As Kinase Inhibitors
App 20160368924 - Chen; Wei ;   et al.
2016-12-22
Therapeutically active compositions and their methods of use
Grant 9,512,107 - Cianchetta , et al. December 6, 2
2016-12-06
Therapeutically Active Compositions And Their Methods Of Use
App 20160318903 - Cianchetta; Giovanni ;   et al.
2016-11-03
Therapeutically Active Compounds And Their Methods Of Use
App 20160304556 - Popovici-Muller; Janeta ;   et al.
2016-10-20
Purinone compounds as kinase inhibitors
Grant 9,469,642 - Chen , et al. October 18, 2
2016-10-18
Therapeutically Active Compositions And Their Methods Of Use
App 20160264621 - Popovici-Muller; Janeta ;   et al.
2016-09-15
Therapeutically Active Compositions And Their Methods Of Use
App 20160229876 - Cao; Sheldon ;   et al.
2016-08-11
Compounds and their methods of use
Grant 9,303,002 - Lemieux , et al. April 5, 2
2016-04-05
Inhibitors Of Bruton's Tyrosine Kinase
App 20160002241 - CHEN; Wei ;   et al.
2016-01-07
Inhibitors Of Bruton's Tyrosine Kinase
App 20160002225 - CHEN; Wei ;   et al.
2016-01-07
N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators
Grant 9,221,792 - Salituro , et al. December 29, 2
2015-12-29
Therapeutic compounds and compositions
Grant 9,199,968 - Salituro , et al. December 1, 2
2015-12-01
Glutamase Inhibitors And Method Of Use
App 20150299152 - Lemieux; Rene M. ;   et al.
2015-10-22
Therapeutic Compounds And Compositions
App 20150299115 - Popovici-Muller; Janeta ;   et al.
2015-10-22
Therapeutic Compounds And Compositions
App 20150183760 - Salituro; Francesco G. ;   et al.
2015-07-02
Therapeutically Active Compounds And Their Methods Of Use
App 20150087600 - Popovici-Muller; Janeta ;   et al.
2015-03-26
Therapeutic compounds and compositions
Grant 8,889,667 - Salituro , et al. November 18, 2
2014-11-18
Therapeutic Compounds And Compositions
App 20140323467 - Salituro; Francesco G. ;   et al.
2014-10-30
Therapeutically Active Compositions And Their Methods Of Use
App 20140213580 - Cao; Sheldon ;   et al.
2014-07-31
Therapeutically Active Compositions And Their Methods Of Use
App 20140206673 - Cao; Sheldon ;   et al.
2014-07-24
Therapeutic compounds and compositions
Grant 8,785,450 - Salituro , et al. July 22, 2
2014-07-22
Compounds And Their Methods Of Use
App 20140142146 - Lemieux; Rene M. ;   et al.
2014-05-22
Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
Grant 8,716,318 - Yan , et al. May 6, 2
2014-05-06
Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
Grant 8,673,919 - Vernier , et al. March 18, 2
2014-03-18
Novel N-(4-(azetidine-1-carbonyl) Phenyl) - (hetero-) Arylsulfonamide Derivatives As Pyruvate Kinase M2 (pmk2) Modulators
App 20140073625 - Salituro; Francesco G. ;   et al.
2014-03-13
Therapeutically Active Compounds And Their Methods Of Use
App 20130190287 - Cianchetta; Giovanni ;   et al.
2013-07-25
Therapeutically Active Compositions And Their Methods Of Use
App 20130184222 - Popovici-Muller; Janeta ;   et al.
2013-07-18
Therapeutic Compounds And Compositions
App 20120172349 - Salituro; Francesco G. ;   et al.
2012-07-05
Dihydropyridin Sulfonamides And Dihydropyridin Sulfamides As Mek Inhibitors
App 20120107307 - Vernier; Jean-Michel ;   et al.
2012-05-03
Pyridone Sulfonamides And Pyridone Sulfamides As Mek Inhibitors
App 20110112152 - Yan; Shunqi ;   et al.
2011-05-12
Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
Grant 7,897,624 - Yan , et al. March 1, 2
2011-03-01
Therapeutic Compounds And Compositions
App 20100331307 - Salituro; Francesco G. ;   et al.
2010-12-30
N-aryl-N'alkyl sulfamides as MEK inhibitors
Grant 7,842,836 - Yan , et al. November 30, 2
2010-11-30
Pyridone Sulfonamides And Pyridone Sulfamides As Mek Inhibitors
App 20070244164 - Yan; Shunqi ;   et al.
2007-10-18
N-aryl-n'alkyl Sulfamides As Mek Inhibitors
App 20070238710 - Yan; Shunqi ;   et al.
2007-10-11
Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus
App 20060217390 - Gunic; Esmir ;   et al.
2006-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed